by M Kumar 2024 Cited by 71A dose of 10 mg TID improves a range of gastroparesis-related symptoms. azithromycin and erythromycin in accelerating gastric emptying
Azithromycin has been compared with erythromycin during small bowel manometry in 30 patients with gastroparesis. Doses of erythromycin were 250 mg IV and azithromycin 250 500 mg. Azithromycin at these doses had similar improvement in motility.
Azithromycin is not currently approved to treat gastroparesis, and its use for this purpose seems to have more risks than benefits. Pharmacists should intervene to prevent IV azithromycin from being ordered for gastroparesis treatment, especially when prescribed at an inappropriate dosing frequency.
Gastroparesis associated with high-dose cytosine arabinoside. Intern Azithromycin in an older woman with diabetic gastroparesis. Am
The prokinetic properties of azithromycin may make it useful in the treatment of small bowel dysmotility and gastroparesis. Ghrelin agonists.
by JA Bonino 2024Escalated dosing of tegasarod for the treatment of gastroparesis. Abstract Azithromycin: A new therapy for gastroparesis? Gastroenterolgy, 2024;128
NCT , Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis. Azithromycin (DB ) Erythromycin (
Azithromycin has been compared with erythromycin during small bowel manometry in 30 patients with gastroparesis. Doses of erythromycin were 250 mg IV and azithromycin 250 500 mg. Azithromycin at these doses had similar improvement in motility.
in diabetic gastroparesis by erythromycin Relationship of adverse events to serum drug levels in patients receiving high- dose azithromycin for mycobacterial
Comments